Neuropsychiatrie disorders in Parkinson's disease and their correction with the MAO-B inhibitor rasagiline (Azilect®)
Parkinson's disease (PD) is a multisystemic neurodegenerative disease with a broad spectrum of not only movement, but also neuropsychiatry disorders (NPD). The efficiency of dopamine therapy in correcting NPD needs to be clarified. Objective: to evaluate the impact of therapy with the MAO-B inh...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2011-09-01
|
| Series: | Nevrologiâ, Nejropsihiatriâ, Psihosomatika |
| Subjects: | |
| Online Access: | https://nnp.ima-press.net/nnp/article/view/314 |